Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Esperas Pharma Inc.

1610-1255 Robert-Bourassa Boulevard, H3B 3X3

About the sponsor

Esperas Pharma Inc. is focused on clinical research in advanced cancer and metastatic cancer, with activity centered on solid tumour treatment settings.

  • Advanced or metastatic cancer
  • Solid tumour oncology
  • Anti-cancer therapeutics

The sponsor’s current research interest includes high-grade serous ovarian cancer, particularly within patients whose disease characteristics guide selection of targeted and combination treatment approaches.

About Specializations

Esperas Pharma Inc. runs clinical trials in conditions such as Neoplasm malignant, Ovarian cancer, Ovarian cancer metastatic, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Neoplasm malignant+2

Not recruiting
Registered drugNo placebo
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Gemcitabine
  • Sponsor:Esperas Pharma Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.